We report a systematic probing of the structural requirements of the bradykinin (BK) type 2 (B2) receptor for antagonist activity by incorporating N-alkyl-amino acid residues at positions 7 and 8 of a potent antagonist sequence. Compound 1 (d-Arg0-Arg 1-Pro 2-Hyp 3-Gly 4-Thi 5-Ser 6-d-Tic 7-N-Chg 8-Arg 9, CP-0597) 1, 2 is a potent (p A 2= 9.3, rat uterus; p K i= 9.62, binding, human receptor clone) B2 receptor antagonist devoid of in vitro B1 antagonist ...